Weycker, D <br/><br/>
Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine.  [electronic resource] 

 -  Journal of human hypertension  May 2007 
 - 374-80 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9240 
<br/><br/><label>Standard No.: </label>10.1038/sj.jhh.1002159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amlodipine--therapeutic use<br/>Antihypertensive Agents--adverse effects<br/>Databases, Factual<br/>Diabetes Mellitus--chemically induced<br/>Diabetes Mellitus, Type 2--chemically induced<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Risk Reduction Behavior<br/>Tetrazoles--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>United States--epidemiology<br/>Valine--analogs & derivatives<br/>Valsartan